ArticleCancer immunology, immunotherapy : CII2012

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Kevin H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.